Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP2 | P42575 | 1/20 | 0.53 |
| ▸ | FAAH | O00519 | 6/20 | 0.51 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.51 |
| ▸ | NAAA | Q02083 | 1/20 | 0.50 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.49 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10359007 | 0.95 | FAAH (0.53) | CASP2FAAHEPHX2NAAANOD1 | |
| SCHEMBL10088105 | 0.89 | LMNA (0.44) | CASP2FAAHEPHX2NOD1ALDH1A1 | |
| SCHEMBL18557505 | 0.85 | CASP2 (0.54) | CASP2FAAHEPHX2NAAANOD1 | |
| SCHEMBL10088131 | 0.84 | CASP2 (0.56) | CASP2FAAHEPHX2NAAANOD1 | |
| SCHEMBL23220238 | 0.84 | KMT2A (0.59) | CASP2NAAASMN1; SMN2ALDH1A1HPGD | |
| SCHEMBL10088127 | 0.84 | NOD1 (0.46) | FAAHEPHX2NOD1DNM1SMN1; SMN2 | |
| SCHEMBL12666301 | 0.83 | CASP2 (0.59) | CASP2FAAHEPHX2NAAANOD1 | |
| SCHEMBL47703 | 0.83 | CASP2 (0.59) | CASP2FAAHEPHX2NAAANOD1 | |
| SCHEMBL28393843 | 0.82 | CASP2 (0.61) | CASP2FAAHEPHX2NAAADNM1 | |
| SCHEMBL194727 | 0.82 | GPR84 (0.54) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8092782-B2 | Polybiotin compounds of magnetic resonance imaging and drug delivery | THE GENERAL HOSPITAL CORPORATION (US) | 2012-01-10 | — | — | US | disclosed |